Lei Cheng

3.1k total citations · 1 hit paper
75 papers, 1.8k citations indexed

About

Lei Cheng is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Lei Cheng has authored 75 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 27 papers in Oncology and 18 papers in Cancer Research. Recurrent topics in Lei Cheng's work include RNA modifications and cancer (13 papers), Cancer Immunotherapy and Biomarkers (12 papers) and Lung Cancer Treatments and Mutations (10 papers). Lei Cheng is often cited by papers focused on RNA modifications and cancer (13 papers), Cancer Immunotherapy and Biomarkers (12 papers) and Lung Cancer Treatments and Mutations (10 papers). Lei Cheng collaborates with scholars based in China, United States and Norway. Lei Cheng's co-authors include Baorui Liu, William S. York, James Atwood, Ron Orlando, Gerardo Álvarez-Manilla, Huimin Zhou, Jia Li, Xiaobo Song, Lifen Zhao and Hengjun Gao and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Water Research.

In The Last Decade

Lei Cheng

65 papers receiving 1.8k citations

Hit Papers

Recent development of multi-target VEGFR-2 inhibitors for... 2023 2026 2024 2025 2023 25 50 75

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lei Cheng China 22 1.1k 511 378 234 228 75 1.8k
Shuhong Wu China 27 1.1k 0.9× 499 1.0× 307 0.8× 162 0.7× 167 0.7× 81 1.9k
José Andrés Yunes Brazil 30 1.7k 1.5× 566 1.1× 600 1.6× 307 1.3× 185 0.8× 129 3.1k
Mayank Singh India 23 1.4k 1.3× 682 1.3× 595 1.6× 265 1.1× 314 1.4× 66 2.5k
Roberta Frapolli Italy 27 1.0k 0.9× 647 1.3× 297 0.8× 224 1.0× 440 1.9× 85 2.3k
Michael Timm United States 27 1.1k 1.0× 526 1.0× 146 0.4× 234 1.0× 148 0.6× 76 2.3k
Shulan Zhang China 29 1.0k 0.9× 535 1.0× 327 0.9× 642 2.7× 138 0.6× 123 2.5k
Geng Zhang China 18 1.5k 1.3× 764 1.5× 899 2.4× 411 1.8× 283 1.2× 76 2.5k
Xingyu Liu China 24 761 0.7× 340 0.7× 284 0.8× 218 0.9× 368 1.6× 129 1.7k
Leila Farahmand Iran 23 849 0.8× 552 1.1× 404 1.1× 238 1.0× 214 0.9× 74 1.7k
Bo Hong China 24 790 0.7× 564 1.1× 358 0.9× 196 0.8× 160 0.7× 80 1.6k

Countries citing papers authored by Lei Cheng

Since Specialization
Citations

This map shows the geographic impact of Lei Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lei Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lei Cheng more than expected).

Fields of papers citing papers by Lei Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lei Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lei Cheng. The network helps show where Lei Cheng may publish in the future.

Co-authorship network of co-authors of Lei Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Lei Cheng. A scholar is included among the top collaborators of Lei Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lei Cheng. Lei Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Li, Zongjuan, Du He, Yijun Jia, et al.. (2024). SLC40A1+ macrophages contribute to the immunosuppressive tumor microenvironment in EGFR-mutated lung cancer. Science Bulletin. 70(1). 47–50. 2 indexed citations
4.
Gao, Zezheng, Wenhui Zhang, Lisha He, et al.. (2024). Double-blinded, randomized clinical trial of Gegen Qinlian decoction pinpointsFaecalibacteriumas key gut bacteria in alleviating hyperglycemia. Precision Clinical Medicine. 7(1). pbae003–pbae003. 11 indexed citations
5.
Wang, Haowei, et al.. (2024). Clinical characteristics and risk factors of non-mild outcomes in patients with Omicron variant COVID-19 in Shanghai, China. The Journal of Infection in Developing Countries. 18(1). 44–52.
6.
Luo, Zhiqiang, Yuxuan Li, Leyao Shen, et al.. (2024). Efficacy of laser adjuvant therapy in the management of post‐operative endodontic pain: A systematic review and meta‐analysis. International Endodontic Journal. 57(12). 1700–1716.
7.
Xu, Yaning, Fengxi Li, Yuyang Liu, et al.. (2024). Directed evolution of Escherichia coli surface-displayed Vitreoscilla hemoglobin as an artificial metalloenzyme for the synthesis of 5-imino-1,2,4-thiadiazoles. Chemical Science. 15(20). 7742–7748. 11 indexed citations
8.
Han, Ruoshuang, Haoyue Guo, Jinpeng Shi, et al.. (2024). Osimertinib in combination with anti-angiogenesis therapy presents a promising option for osimertinib-resistant non-small cell lung cancer. BMC Medicine. 22(1). 174–174. 11 indexed citations
9.
Bai, Hao, et al.. (2024). Genetic mutation profiling reveals biomarkers for targeted therapy efficacy and prognosis in non-small cell lung cancer. Heliyon. 10(6). e27633–e27633. 1 indexed citations
10.
Liu, Xiujuan, Haojie Zhang, Lei Cheng, et al.. (2023). Recent development of multi-target VEGFR-2 inhibitors for the cancer therapy. Bioorganic Chemistry. 133. 106425–106425. 93 indexed citations breakdown →
11.
Cheng, Lei, Guanghui Gao, Chao Zhao, et al.. (2023). Personalized circulating tumor DNA detection to monitor immunotherapy efficacy and predict outcome in locally advanced or metastatic non‐small cell lung cancer. Cancer Medicine. 12(13). 14317–14326. 4 indexed citations
12.
Yi, Yue, Jan Dolfing, Jin Ge, et al.. (2023). Thermodynamic restrictions determine ammonia tolerance of methanogenic pathways in Methanosarcina barkeri. Water Research. 232. 119664–119664. 26 indexed citations
13.
Cheng, Lei, et al.. (2022). Mechanisms of bone remodeling and therapeutic strategies in chronic apical periodontitis. Frontiers in Cellular and Infection Microbiology. 12. 908859–908859. 52 indexed citations
14.
Long, Hongan, Samuel F. Miller, Chaoxian Zhao, et al.. (2016). Antibiotic treatment enhances the genome-wide mutation rate of target cells. Proceedings of the National Academy of Sciences. 113(18). E2498–505. 155 indexed citations
15.
Zhang, Jingyu, Li Xie, Jing Hu, et al.. (2016). Antitumor effect of manumycin on colorectal cancer cells by increasing the reactive oxygen species production and blocking PI3K-AKT pathway. OncoTargets and Therapy. 9. 2885–2885. 18 indexed citations
16.
Chen, Xi, et al.. (2015). Rapid screening and confirmation of 205 pesticide residues in rice by QuEChERS and liquid chromatography-mass spectrometry. Chinese Journal of Chromatography. 33(10). 1080–1080. 1 indexed citations
17.
Qian, Xiaoping, et al.. (2015). Combination of cetuximab and PP242 synergistically suppress the progression of wild-type KRAS colorectal carcinoma. OncoTargets and Therapy. 8. 3185–3185. 5 indexed citations
18.
Cheng, Lei, Ming Li, Jing Hu, et al.. (2014). UGT1A1*6 polymorphisms are correlated with irinotecan-induced toxicity: a system review and meta-analysis in Asians. Cancer Chemotherapy and Pharmacology. 73(3). 551–560. 64 indexed citations
19.
Cheng, Lei, Qing Zhang, Sheng Yang, et al.. (2013). A 4-gene panel as a marker at chromosome 8q in Asian gastric cancer patients. Genomics. 102(4). 323–330. 27 indexed citations
20.
Cheng, Lei. (2002). B7 family-important co-stimulatory molecules. Immunological Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026